Dunedin Income Growth Investment Trust PLC (DIG) — Research Note

Executive summary

DIG is a £360m closed-end UK equity income investment trust managed by abrdn (Aberdeen Group), holding a concentrated portfolio (~32 names) of "Quality/Growth" UK and selected European listed equities with a sustainability overlay 2025-09 half-year. Operating trajectory across the period covered (FY Jan-2021 to H1 FY-Jan-2026) has been steady absolute returns but persistent NAV underperformance vs the FTSE All-Share, driven by a Quality style headwind; NAV per share is broadly flat at ~318p over five years while dividend per share has been raised ~50% (to a new 19.10p run-rate from FY-Jan-2026 — yield ~6.4%) 2025-12 third interim dividend; 2025-09 half-year. The single most important point for valuation is mechanical: the trust trades at an 8.4–14% discount to NAV — the share price IS the valuation, and the asset value comes from listed underlying holdings priced daily.

Fair value estimate

Methodology: NAV-based, with a small discount band reflecting closed-end structure norms.

• Last reported NAV per share (debt at fair value, 31 Jul 2025): 324.28p, on 127.15m shares ⇒ NAV market cap £412m 2025-09 half-year.
• Current market cap (£362.1m) implies share price of ~285p, i.e. a ~12% discount to last-reported NAV.
• Fair value range: 305p – 325p, implied market cap £388m – £413m.
  • Low end: trust at a typical 5–6% sector discount.
  • High end: trust at NAV (achievable if dividend reset + Quality rotation closes the gap).
• vs current £362m mcap (285p): +7% to +14% upside, mid ~+11%.
• Caveat: NAV is itself a function of UK equity prices and will move with the FTSE All-Share between now and any rerating; the discount-closure component is the only DIG-specific alpha.

Sector context

Classification confirmed: Financials / Financial Services (UK-listed investment trust / closed-end fund). Within the AIC UK Equity Income peer group, DIG sits with a quality/sustainability tilt; gearing (7.1% net) is modest vs peers; ongoing charges 0.59% are competitive 2025-09 half-year. Closest listed peers: City of London Investment Trust (CTY), Murray Income Trust (MUT), Edinburgh Investment Trust (EDIN), Finsbury Growth & Income (FGT) for the quality-tilt comparison. DIG's quality/yield blend is above-average; recent NAV performance is below the peer median.

Investment thesis

• 6%+ dividend yield underwritten by a new policy of 6.0% of NAV, distributed using both revenue and capital reserves — total dividend rebased +34.5% to ≥19.10p 2025-12 third interim dividend. The Board explicitly intends a progressive dividend from this new base.
• Persistent ~10% discount + active buybacks (7.8m shares bought back in H1 FY-Jan-2026 at avg 8.8% discount, adding ~0.5% to NAV/share) provide a structural tailwind to per-share NAV 2025-09 half-year.
• Quality/Growth style has underperformed for the longest stretch in 25 years, leaving the portfolio's premium-to-market on quality metrics at a multi-year low (just 7%) despite 60% higher ROE, 25% higher operating margins, and 20% less gearing than the index 2025-09 half-year. Mean-reversion of style would be a meaningful tailwind.

Key risks

• NAV total return has lagged the FTSE All-Share materially in H1 FY-Jan-2026 (3.1% vs 7.5%), extending a multi-year run of relative underperformance — funding the higher dividend from capital risks shrinking the asset base if performance does not improve 2025-09 half-year.
• Style risk: Quality remains out of favour; benchmark returns have been driven by sectors DIG cannot/will not hold (Banks, Tobacco, Aerospace & Defence) — there is no near-term catalyst for the regime to change 2025-09 half-year.
• Manager concentration/parent risk: managed by abrdn (Aberdeen Group), which has been through prolonged outflows and brand turmoil; key-person reliance on portfolio managers Ben Ritchie and Rebecca Maclean (not disclosed but inferred).

Operating leverage

DIG has essentially no operating leverage in the equity-research sense. Its cost base is a management fee (tiered: 0.45% on first £225m, 0.35% on next £200m, 0.25% above) plus administrative expenses; ongoing charges ratio is 0.59% of average NAV 2025-09 half-year, note 11. Costs scale linearly with assets, so a 10–20% upside revenue surprise from the underlying portfolio translates into roughly the same uplift in fee-adjusted NAV — there is no fixed-cost gearing to amplify it. The only true amplifier is the balance-sheet gearing of ~7% net (£30m 3.99% Loan Notes maturing 2045 + £19.5m drawn from £30m RCF), which scales returns roughly 1.07x in either direction. There are no SaaS-style inflection points, network effects, or capacity utilisation curves to monitor — this is a fund, not an operating business. For a portfolio with limited operating leverage characteristics, the AI-driven long-tail-of-outcomes thesis is largely absent here.

Value-trap signals

• NAV total return has trailed the benchmark for an extended period — recent commentary describes a "frustrating period for relative performance" 2025-09 half-year.
• Revenue earnings per share fell 12.3% H1-on-H1 to 7.82p (lower option income, smaller equity base post-buybacks) — the higher dividend is partially capital-funded, not earnings-funded 2025-09 half-year.
• Discount has been persistently in the 8–14% band for two-plus years despite buybacks and a dividend reset — the market is not yet re-rating the vehicle.
• Mitigants: clean accounting; Level-1 quoted equities only; transparent gearing; no related-party concerns. So not a structural value trap, but a "patience required" cheap-ish vehicle.

Earnings vs. expectations

For an investment trust there is no analyst EPS consensus in the traditional sense; the relevant scorecard is NAV total return vs benchmark (FTSE All-Share):

Pattern: two strong relative years (FY-Jan-2024) followed by two consecutive halves of meaningful underperformance, driven by Quality-style headwinds and underweights in Banks/Tobacco/Aerospace & Defence which led the index. Revenue EPS also undershot the prior period in H1 FY-Jan-2026 (-12.3%) due to lower option-writing income.

Conviction

Conviction: 4 (high) — for the fair-value call, not for a "buy" call.

• Anchors: (i) NAV is published daily and the underlying assets are 100% Level-1 quoted equities, so fair value is observable, not modelled; (ii) discount/premium history gives a clear band for re-rating; (iii) clean Deloitte-audited disclosure.
• Limits: (i) the actual NAV next quarter depends on UK equity market levels, not anything DIG-specific; (ii) the discount has been stubborn despite buybacks + dividend reset — predicting when (if) it closes is the speculative part.

Driver scoring & rationale

This portfolio is a poor structural fit for the investor profile described: it is a diversified UK quality-income trust with only diluted, indirect AI exposure (ASML 1.8%, Sage 2.8%, Softcat 2.2%, Oxford Instruments 2.2%, RELX 5.0%, LSEG 3.6%, AstraZeneca 2.5% — collectively ~20% of NAV), no operating leverage of its own, and underlying constituents that are largely mature large-caps. Valuation is fair (discount = built-in margin of safety), downside protection is sound (Level-1 liquid assets, modest gearing, clean accounts), but the AI-receiver + operating-leverage pillars are essentially missing. Overall fit score reflects that mismatch — it would be a reasonable diversifying income holding but not a long-tail-of-outcomes AI bet.